Table 2.
Postoperative characteristics and outcome.
| Total (n = 27) | Open thoracoabdominal aortic aneurysm (TAAA)-repair (n = 17) | Endovascular TAAA repair (n = 10) | p-Value | |
|---|---|---|---|---|
| Creatinine (mg/dL) (IQR) | 0.9 (0.6–1.7) | 1.1 (0.7–1.4) | 0.6 (0.3–0.6) | 0.14 |
| Urea (mg/dL) (IQR) | 30.5 (20.8–37.0) | 30.5 (19.8–35.3) | 35.5 (29.3–41.0) | 0.04 |
| Hemoglobin (g/dL) (IQR) | 10.9 (9.9–12.1) | 11.2 (10.0–12.4) | 10.4 (9.7–11.0) | 0.24 |
| Platelets (109 cells/L) (IQR) | 125.5 (99.3–138.5) | 125.5 (92.3–138.5) | 129.0 (106.3–166.8) | 0.27 |
| White cells (109 cells/L) (IQR) | 8.8 (6.4–12.0) | 7.7 (6.1–12.1) | 12.0 (6.0–12.0) | 0.73 |
| ALT (U/L) (IQR) | 22.5 (16.8–46.8) | 22.5 (17.0–46.8) | 20.5 (9.3–66.3) | 0.16 |
| AST (U/L) (IQR) | 34.5 (26.8–93.8) | 34.5 (26.8–93.8) | 51.5 (20.8–97.3) | 0.07 |
| Gamma-GT (U/L) (IQR) | 16.5 (12.8–29.0) | 16.5 (12.0–27.5) | 20.5 (13.3–37.5) | 0.63 |
| Bilirubin (mg/dL) (IQR) | 1.0 (0.4–1.6) | 1.2 (0.7–1.6) | 0.6 (0.3–2.6) | 0.03 |
| Interleukin-6 (pg/mL) (IQR) | 111.3 (16.1–184.2) | 113.4 (60.2–229.6) | 43.4 (4.8–164.0) | 0.20 |
| PCT (ng/mL) (IQR) | 0.03 (0.03–0.07) | 0.03 (0.03–0.18) | 0.04 (0.02–0.04) | 0.50 |
| CRP (mg/dL) (IQR) | 5.1 (3.8–5.6) | 5.3 (4.0–19.4) | 0.8 (0.4–0.8) | 0.77 |
| Lactate (mM/L) (IQR) | 1.8 (0.8–6.0) | 3.6 (1.3–6.1) | 0.5 (0.3–0.5) | 0.03 |
| Lactate clearance (%) (IQR) | −25.0 (−55.0–8.3) | −37.5 (−63.4–6.3) | −11.0 (−36.4–32.3) | 0.10 |
| Cristalloids within first 24 h (L) (IQR) | 2.7 (2.2–3.6) | 2.7 (2.2–3.8) | 2.8 (2.2–3.2) | 0.05 |
| Colloids within first 24 h (L) (IQR) | 0.5 (0.0–1.1) | 0.8 (0.4–1.5) | 0.3 (0.0–0.5) | 0.14 |
| Diuresis within first 24 h (L) (IQR) | 1.3 (0.7–2.0) | 1.3 (0.9–2.6) | 1.0 (0.7–1.3) | 0.51 |
| Maximal Noradrenaline within first 24 h (μg/kg/min) (IQR) | 0.06 (0.01–0.34) | 0.08 (0.02–0.29) | 0.03 (0.0–0.44) | 0.81 |
| SAPS (points) (IQR) | 44.0 (21.0–48.0) | 44.0 (19.5–47.0) | 44.0 (22.5–48.3) | 0.51 |
| SOFA (points) (IQR) | 8.0 (4.0–11.0) | 6.0 (4.5–11.0) | 8.5 (2.8–11.3) | 0.80 |
| APACHE II (points) (IQR) | 21.0 (12.0–25.0) | 19.0 (12.5–24.0) | 22.0 (11.8–28.0) | 0.45 |
| MV (hours) (IQR) | 16.8 (11.0–42.3) | 22.8 (12.4–544.8) | 15.4 (9.7–26.5) | 0.36 |
| Acute kidney injury (%) | 5 (18.5) | 3 (17.6) | 2 (20.0) | 0.69 |
| LOS intensive care unit (days) (IQR) | 4.0 (1.0–7.0) | 4.0 (1.5–6.5) | 3.5 (1.0–11.5) | 0.82 |
| 90-day EQ-VAS score (points) (IQR) | 55.0 (50.0–72.5) | 65.0 (50.0–85.0) | 50.0 (13.8–61.3) | 0.06 |
| 90-day mortality (%) | 3 (11.1) | 3 (17.6) | 0 (0.0) | 0.13 |
Categorical and continuous variables are presented as n (%) and median (interquartile ranges, IQR), respectively. Kruskal–Wallis test was used to compare categorical and continuous variables between patients undergoing open or endovascular TAAA repair, respectively.
ALT, alanine aminotransferase; AST, aspartate aminotransferase; APACHE II, Acute Physiology and Chronic Health Evaluation II Score; BMI, body mass index; CRP, C-reactive protein; eGFR, estimated glomerular filtration rates; EQ-VAS, EuroQol visual analog scale; gamma-GT, gamma-glutamyl transferase; IL, interleukin; LOS, length of stay; MV, mechanical ventilation; PCT, procalcitonin; SAPS, Simplified Acute Physiology Score; SOFA, Sequential Organ Failure Assessment Score.